MD Conference Express TCT 2011 - (Page 3)

HIGHLIGHTS FROM THE: Transcatheter Cardiovascular Therapeutics The European Society of Cardiology 2011 Interventional Conference 2008 Annual Meeting November 7-11, 2011 San Francisco, Munich, Germany CA, USA LEAD CARDIOLOGY ADVISORS Clinical Trial Highlights 4 5 TAVI Improves QoL in Patients Suitable for Transfemoral TAVI: PARTNER Cohort A Results from the PARTNER Trial (Cohort A): Transfemoral TAVI Economically Attractive but Transapical TAVI More Costly PARTNER Cohort B: TAVI Superior to Standard Therapy at Two Years Transapical TAVI Inferior to SAVR in Operable Elderly Patients Primary Results from ADVISE: Validation of a Vasodilator Independent Measure of Coronary FFR Point-of-Care Genetic Testing Facilitates Rapid Personalization of Antiplatelet Therapy Bioabsorbable Polymer Stent Noninferior to Permanent Polymer Stent Peer-Reviewed CARDIOLOGY Scientific Sessions PRESENTS HIGHLIGHTS FROM THE Transcatheter Cardiovascular Therapeutics 2011 Interventional Conference Breaking News August 30—September 4, 2008 5 6 7 Gregory R. Giugliano, MD, SM Baystate Medical Center, USA Robert P Giugliano, MD, SM . Brigham and Women’s Hospital, USA Therapy Updates November 7-11, 2011 San Francisco, CA, USA TAVI Improves QoL in Patients Suitable for Transfemoral TAVI Transcatheter aortic valve implantation (TAVI) is a less invasive alternative to surgical aortic valve replacement (SAVR) for high-risk patients with aortic stenosis. In PARTNER [NCT00530894; Leon MB et al. NEJM 2010] Cohort A, TAVI was shown to be noninferior to SAVR for 1-year mortality in patients who were at high surgical risk. There were differences in procedurerelated complications and valve performance at 1 year, with some endpoints favoring TAVI and others favoring SAVR. See page 4. INTERNATIONAL MEDICAL ADVISORY BOARD INTERNATIONAL MEDICAL ADVISORY BOARD Philip E Aylward, BM BCh, PhD Mariell Jessup, MD, FAHA Olakunle O. Akinboboye, MD Flinders Medical Centre, Australia New York Hospital Queens Edmund Chada Baracat, MD Martin J. Abrahamson, MD Scientific Director, Beth Israel Deaconess Brazilian Medical Association Medical Center Jeroen J. Bax, MD, PhD Joslin Diabetes Center Leiden University Medical Center Heinz Burgmann, MD The Netherlands University Bergenstal, MD Richard M. of Vienna A Professional Courtesy of • Point-of-Care Genetic Testing ALSO IN THIS ISSUE • BRIDGE Study Results • PARTNER Cohort Subanalyses Roberto R. Giraldez, MD Scientific Sessions Program Chair, American Heart Association Heart Institute - Hospital das Clinicas Milan Luknar, MD Frank Institute of Cardiovascular NationalC. Messineo, MD Disease, Hospital Queens New York Slovak Republic 8 9 Raymond Massay, MD Tore Kvien, MD President, Diakonhjemmet Hospital, Caribbean Cardiac Society Past-President, EULAR ErnestoE. Nussbaum, Paolasso, MD Harold J. Burstein, MD, PhD Michel President, Medicine & Science, Instituto de Investigaciones MD, FACP American Diabetes Association Dana-Farber Cancer Insitute Clínicas Hospital Queens New Yorkde Rosario, Argentina Marc P Bonaca, MD, MPH PhD . Daniel J. DeAngelo, MD, Anne L. Peters,MD FACP CDE , Patrick Ying, MD, Brigham and Women’s Hospital, USA Dana-Farber Cancer Institute Univ. Medical Center of Southern California, USA NYU Ramon W. Falk, MD, MS Gary Corbalán, MD Fausto Pinto, MD Pontificia Universidad Católica, Chile Joanna J. Wykrzykowska, MD Cleveland Clinic CPC Chair, European Society of Beth Israel Deaconess Anthony J. Dalby MB, ChB, FCP Cardiology Congress 2009-2010 Apostolos Georgopoulos, MD Medical Center Milpark Hospital, South Africa University of Vienna Hiroaki Shimokawa, MD, PhD Jean-Pierre Després, MD, SM Editor-in Chief, Robert P Giugliano, PhD . Japanese Circulation Journal Université Laval, Canada Brigham & Women’s Hospital Andrew F. Stewart, MD Vivian A. Fonseca, MD, FRCP Past-Chair, ADA Scientific Sessions Tulane University, USA Chuwa Tei, MD Timothy J. Gardner, MD President of the Japanese College Christiana Care Center for EDITORIAL STAFF of Goodwin Heart & Vascular Health Publisher JenniferCardiology Eva Gonçalvesova, MD, PhD BethJacob A. Udell, MD, MPH Vice President, Johnson Brigham and Women's Hospital, USA President, Publishing Slovak Society of Cardiology Heather Q. Sinclair Associate Director, Publishing Production Assistant Lauren Valone STAFF Neil Canavan Medical President Writers Jennifer Goodwin MedCom Depot Vice President, Beth Johnson Publishing Design IntuitDesign Production Manager Lauren Valone Toni Rizzo Medical Writer 10 BRIDGE Study Demonstrates Feasibility and Safety of Cangrelor The editors would like to thank the members of the TCT 2011 presenting faculty who generously gave their time to ensure the accuracy and quality of the articles in this publication. PUBLISHER 98 Oxford Street Suite #1 Arlington, MA 02474 USA Tel.: +1-617-515-9797 E-mail: reports [at] goodwingroupintl.com SALES Jennifer Goodwin Tel.: +1-617-515-9797 BUSINESS DEVELOPMENT Jennifer Goodwin Tel.: +1-617-515-9797 www.mdconferencexpress.com reports [at] goodwingroupintl.com +1-617-515-9797 The publisher does not assume any legal liability or responsibility for the accuracy, completeness, or usefulness of the information supplied herein, nor for any opinion expressed. The publisher, its agents, and employees will not be liable for any loss or damage arising directly or indirectly from the possession, publication, use of, or reliance on information obtained from this report. It is provided in good faith without express or implied warranty. Reference to any specific commercial product or service does not imply endorsement or recommendation by the publisher. All articles are peer-reviewed and protected from any commercial influence. © MD Conference Express. All rights reserved. Neither this publication nor any part of it may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior written permission of The Goodwin Group International, LLC. MD Conference Express is a registered trademark of The Goodwin Group International, LLC. ISSN 1559-8977 ISSN 2155-756X  http://www.mdconferencexpress.com http://www.tctconference.com/ http://www.facebook.com/mdconferencexpress http://visitor.r20.constantcontact.com/manage/optin/ea?v=001BdwJNcIEVTgv4LtUJBUDeg%3D%3D http://www.mdconferencexpress.com

Table of Contents for the Digital Edition of MD Conference Express TCT 2011

MD Conference Express TCT 2011
Contents
TAVI Improves QoL in Patients Suitable for Transfemoral TAVI: PARTNER Cohort A
Results from the PARTNER Trial (Cohort A): Transfemoral TAVI Economically Attractive but Transapical TAVI More Costly
PARTNER Cohort B: TAVI Superior to Standard Therapy at Two Years
Transapical TAVI Inferior to SAVR in Operable Elderly Patients
Primary Results from ADVISE: Validation of a Vasodilator Independent Measure of Coronary FFR
Point-of-Care Genetic Testing Facilitates Rapid Personalization of Antiplatelet Therapy
Bioabsorbable Polymer Stent Noninferior to Permanent Polymer Stent
BRIDGE Study Demonstrates Feasibility and Safety of Cangrelor

MD Conference Express TCT 2011

https://www.nxtbook.com/nxtbooks/md_conference_express/tct2011
https://www.nxtbookmedia.com